The proof of concept of a continuously sensing affinity device based on the glucose-dependent viscosity of a sensitive solution containing dextran and Concanavalin A has been successfully demonstrated. The biosensor incorporates a piezoelectric diaphragm and a flow-resisting microchannel for viscosity detection, and a free-standing Anodic Alumina Oxide (AAO) porous nano-membrane as glucose selective interface. Extensive in vitro glucose measurements between two physiologically relevant glucose concentrations, 2 mM and 9 mM (respectively hypo- and hyperglycemia), were successfully performed during 4 days. To the best of our knowledge, such reversibility and stability of glucose measurement over time had not been reported yet.
Loïc Dayon, Andreas Wiederkehr
Yves Perriard, Yoan René Cyrille Civet, Christian Köchli, Sofia Lydia Ntella, Bhawnath Tiwari, Kenny Jeanmonod
Felix Naef, Nicholas Edward Phillips